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Lymphocytes are implicated in immunity and pathogenesis of severe malaria. Since lymphocyte subsets vary with age, as-
sessment of their contribution to different etiologies can be difficult. We immunophenotyped peripheral blood from Mala-
wian children presenting with cerebral malaria, severe malarial anemia, and uncomplicated malaria (n 113) and healthy
aparasitemic children (n 42) in Blantyre, Malawi, and investigated lymphocyte subset counts, activation, and memory
status. Children with cerebral malaria were older than those with severe malarial anemia. We found panlymphopenia in
children presenting with cerebral malaria (median lymphocyte count, 2,100/l) and uncomplicated malaria (3,700/l),
which was corrected in convalescence and was absent in severe malarial anemia (5,950/l). Median percentages of acti-
vated CD69 NK (73%) and  T (60%) cells were higher in cerebral malaria than in other malaria types. Median ratios of
memory to naive CD4 lymphocytes were higher in cerebral malaria than in uncomplicated malaria and low in severe ma-
larial anemia. The polarized lymphocyte subset profiles of different forms of severe malaria are independent of age. In con-
clusion, among Malawian children cerebral malaria is characterized by lymphocyte activation and increased memory cells,
consistent with immune priming. In contrast, there are reduced memory cells and less activation in severe malaria anemia.
Further studies are required to understand whether these immunological profiles indicate predisposition of some children
to one or another form of severe malaria.
There are approximately 500 million clinical episodes of Plas-modium falciparum malaria each year, leading to around
0.65 million deaths worldwide, most of which occur in African
children (1). Despite promising recent results from the RTS,
S/AS01 phase 3 malaria vaccine trial in African children (2), no
vaccine against malaria is currently available, and resistance of
parasites to different treatments and of mosquitoes to insecti-
cides is a growing problem (3). The development of new ther-
apies and vaccines against malaria would be facilitated by an
improved understanding of the pathogenesis of the disease (4).
The publication of the full genome of P. falciparum in 2002 (5)
has led to greater insights into the biology of the malaria para-
site, its antigenic variability, and its genetic diversity (6). How-
ever, our understanding of the host-pathogen interaction, and
particularly of the host immune response to malaria, is incom-
plete (7).
Immunity tomalaria involves variousmechanisms. Antibodies
that develop through exposure to P. falciparum (8) play a role,
and the involvement of different lymphocyte subsets has been
implicated in both protection against and pathogenesis of ma-
laria (9, 10). Many of the studies on which these findings have
been based have involved the investigation of experimental
malaria in animals or nonimmune volunteers. A number of
clinical studies of lymphocyte populations have been con-
ducted in African children (11–15). The results of these studies
can be difficult to interpret, because large studies usually do not
discriminate between different clinical manifestations of ma-
laria and the lymphocyte subsets investigated are often limited.
Small studies can suffer from insufficient numbers for statisti-
cal analysis and are often focused on one aspect of the immune
response.
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The two main forms of severe malaria, severe malarial ane-
mia and cerebral malaria, occur in children with differing, al-
though overlapping, age distributions, with cerebral malaria
typically afflicting older children (16). In a study of lymphocyte
subsets in healthy Malawians, we found a strong linear trend with
age for the majority of parameters tested, with absolute lympho-
cyte counts decreasing with age (17). Hence, changes in lympho-
cyte subsets with malaria could reflect patient age rather than dis-
ease state. To better understand the pathogenesis of severemalaria
and uncomplicated malaria in a population severely affected by
malaria, we undertook a study of lymphocyte subsets amongMa-
lawian children. Clinical presentation was carefully discriminated
between cerebral malaria, severe malarial anemia, and uncompli-
cated malaria. Patients’ ages were recorded, and lymphocyte
profiles were studied during acute illness and reexamined in
convalescence. We investigated absolute and percent lympho-
cyte counts and lymphocyte activation and memory status.
MATERIALS AND METHODS
Study design and participants. The study was conducted within the
Malawi-Liverpool-Wellcome Trust Clinical Research Programme and
Department of Pediatrics, College of Medicine, University of Malawi,
and Blantyre Malaria Project. Participants were children admitted
with malaria to Queen Elizabeth Central Hospital and medically well
children selected to have approximately the same age range and distri-
bution as study children with malaria attending surgical outpatient
clinics at Queen Elizabeth Central Hospital and Beit Cure Interna-
tional Hospital, both in Blantyre. Children were enrolled during the
rainy season (November to April). Following informed consent from
the parent or guardian, each child was examined by a research nurse
and clinical officer, baseline demographic data were recorded, and a
peripheral blood sample was taken. Children were assessed for level of
consciousness using the Blantyre Coma Score (BCS) on admission and
at 2- to 4-hourly intervals during intensive clinical care. Over 40 chil-
dren were prospectively enrolled into each of the four clinical groups
defined by diagnoses of cerebral malaria, severe malarial anemia, or
uncomplicated malaria or healthy controls.
Malaria was defined as a clinical syndrome without an apparent
alternative cause, in the presence of a thick blood film positive for P.
falciparum asexual parasites on microscopy. Children with cerebral
malaria had a BCS of 2 or less at admission and 4 h later, while children
in all other groups had a score of 5 at both times (Table 1). Children
with severe malarial anemia had a blood hemoglobin concentration of
5 g/dl or less, and all other children had a hemoglobin concentration
above this level. Children who tested positive for HIV infection were
excluded from the study and referred to the antiretroviral therapy
clinic.
Investigations. Investigations were performed on EDTA-anticoag-
ulated blood on the day of venesection. HIV testing was performed
using two rapid tests, Determine (Abbott Laboratories, Tokyo, Japan)
and UniGold (Trinity Biotech, Dublin, Ireland). Discordant results in
all children and positive results in children under 18 months were
confirmed by PCR (18). Thick and thin films were prepared for deter-
mining the density of malaria parasitemia. A full blood count was
performed on an HMX hematological analyzer (Beckman Coulter,
California). For immunophenotyping, 25 l blood was labeled with
monoclonal antibodies in eight tubes according to the procedure de-
scribed in Table S1 in the supplemental material. All antibodies were
from Becton Dickinson (San Jose, CA) (see Table S2). Samples were
processed, and data were acquired using a FACSCalibur flow cytome-
ter and CellQuest software (Becton Dickinson) as previously described
(17). The gating strategy used is shown in Fig. S1 in the supplemental
material.
Statistical analysis. Medians and 10th and 90th percentiles were
determined for absolute and percent lymphocyte subset concentra-
tions in each clinical group at acute presentation and convalescence.
Lymphocyte parameters were compared between control subjects and
children with uncomplicated malaria, severe malarial anemia, and ce-
rebral malaria using nonparametric Kruskal-Wallis tests. To assess
whether age-related variations in lymphocyte counts confounded any
observed associations, we also compared lymphocyte parameters by
nonparametric analysis of covariance (ANCOVA) with age as a cova-
riate in the model, using the sm package in R. Given the multiple
lymphocyte parameters studied, Kruskal-Wallis and nonparametric
ANCOVA P values were corrected for multiple comparisons using
Benjamini-Hochberg adjustments, and adjusted P values of 0.05
TABLE 1 Eligibility criteria for recruitment into study groups
Group
no.
Group name
(abbreviation)
Result for criteriona:
MPS BCS
Hb
(g/dl) HIV
1 Cerebral malaria (CM) Positive 2 5 ve
2 Severe malarial anemia
(SMA)
Positive 5 5 ve
3 Uncomplicated malaria
(UCM)
Positive 5 5 ve
4 Healthy controls Negative 5 5 ve
a Abbreviations: MPS, malaria parasite slide; BCS, Blantyre coma score at presentation
and 4 h later; Hb, hemoglobin; HIV, HIV status;ve, uninfected.
TABLE 2 Participant detailsa
Characteristic
Value for clinical group:
Control Cerebral malaria Severe malarial anemia Uncomplicated malaria
No. of patients
Total 42 29 30 54
Died during admission 4 1 0
Followed up in convalescence 18 21 34
Sex (male/female ratio) 29:13 10:19 19:11 38:16
Median age, mo (range) 20 (5–76) 30 (5–84) 23 (5–38) 27 (6–58)
Median no. of parasites/l blood (range) 0 41,800 (900–517,000) 3,500 (20–296,000) 52,300 (460–768,000)
Median Blantyre coma score (range) 5 1 (0–2) 5 5
Median hemoglobin, g/dl (range) 11.2 (7.0–14.1) 7.7 (5.3–12.5) 3.9 (2.4–4.9) 9.3 (5.1–13.0)
a Subjects were children with cerebral malaria, severe malarial anemia, or uncomplicated malaria presenting to the Pediatric Accident and Emergency Clinic at Queen Elizabeth
Central Hospital in Blantyre, Malawi. Control subjects were children admitted for elective surgical procedures who were medically well.
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were considered significant. For post hoc testing in cases of significant
Kruskal-Wallis and nonparametric ANCOVA tests, Dunn’s test pair-
wise comparisons were performed with Benjamini-Hochberg correc-
tions for multiple comparisons. All statistical analyses were performed
in R.
Ethical approval. The study was approved by the College of Medicine
Research and Ethics Committee, University of Malawi, and the Ethics
Committee of the Liverpool School of Tropical Medicine, United King-
dom. A parent or guardian of each participant provided informed written
consent on the child’s behalf.
RESULTS
Characteristics of study children. Consent was given for 188
children aged 5 to 84 months to participate in the study. Blood
samples from 33 children were excluded for the following rea-
sons: HIV infection (n 14), malaria parasites in the blood of
control subjects (n 14), BCS greater than 2 at 4 h postadmis-
sion in children with suspected cerebral malaria (n  4), and
hemoglobin below 5 g/dl in one child with cerebral malaria.
The baseline characteristics of the remaining 155 children are
presented in Table 2.
Median age was higher for children with cerebral malaria (30
months) than those with severe malarial anemia (23 months)
(Mann-Whitney U test, P 0.007), consistent with the reported
age pattern of these two forms of malaria (16). Five children (four
with cerebral malaria and one with severe malarial anemia) died
during admission. Seventy-three out of 113 children with malaria
returned for follow-up.
Absolute cell counts indicate transient panlymphopenia in
children with cerebral malaria. Children with cerebral malaria
had very low median total lymphocyte counts (2,100/l) com-
pared with children with uncomplicated malaria (3,700/l) (P
 0.002), which, in turn, were lower (P 0.001) than those of
children with severe malarial anemia, who had a median value
similar to that of the control group (5,950/l and 5,250/l,
respectively) (Table 3; Fig. 1). The lymphopenia in these first
two groups affected overall T and B lymphocyte subsets, as well
as CD4 and CD8 T cell subsets (Table 3; Fig. 2). These
changes are independent of age-related changes in lymphocyte
counts. Despite the similarity of the median total lymphocyte
counts in children with severe malarial anemia and in control
children, the range of total lymphocyte counts among those
with severe malarial anemia was broader. Median convalescent
total lymphocyte counts were similar to counts of the control
group for all malaria groups, indicating that the panlymphope-
nia of malaria is transient. Lymphocyte subset counts were
normalized during convalescence following each form of ma-
laria, and there were no significant differences between counts
for each lymphocyte subset in each clinical group in convales-
cence and controls (Table 3).
Numbers of activated innate lymphocytes increase in ma-
laria. All forms of malaria were associated with increased num-
bers of lymphocytes expressing the acute activation marker
CD69 (Table 4; Fig. 3). This was particularly marked for innate
lymphocytes, NK cells, and 	 T cells (for each acute malaria
group compared to control group, P 0.001) andmost evident
in children with cerebral malaria (median values of CD69
cells, 73% for NK cells and 60% for 	 T cells). Median CD69-
expressing lymphocytes were normalized in convalescence.
Cerebralmalaria is associated with increased proportions of
memory CD4 T cells. Using CD45RO and CD45RA to distin-
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FIG 1 Lymphocyte subset counts in children with cerebral malaria (CM), severe malaria anemia (SMA), or uncomplicated malaria (UCM) and aparasitemic
children. Total, T, B, NK, andNKT cell counts in peripheral blood at acute presentationwith CM (turquoise), SMA (dark blue), or UCM (green) comparedwith
healthy children (red). Counts shown for individual children against age with nonparametric regression line (left column) and box-and-whisker plots (middle
column; boxes, interquartile ranges; whiskers, data ranges excluding outliers). Tables (right column) give Dunn’s pairwise post hoc comparisons of groups where
Kruskal-Wallis and nonparametric ANCOVA comparisons of data across groups gave P values of0.05. All P values were adjusted with Benjamini-Hochberg
corrections for multiple comparisons.
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guish memory and naive T cells, respectively, we found a high
ratio of memory to naive CD4 lymphocytes in cerebral and un-
complicated malaria (median ratios, 0.85 and 0.62, respectively)
compared with controls and children with severe malarial anemia
(both 0.40) (cerebralmalaria or uncomplicatedmalaria compared
to severe malarial anemia or controls, P  0.001 for all pairwise
comparisons, except uncomplicated malaria and severe malarial
anemia, where P was 0.002) (Table 4; Fig. 4). Despite children in
cerebral and uncomplicated malaria groups being generally
older than those with severe malarial anemia and controls, the
differences between groups were apparent at all ages but did
not persist in convalescence (Table 4). In contrast, there was no
significant increase in memory to naive CD8 T cells in any
form of malaria compared with controls. The median ratios of
memory to naive B cells (indicated by the presence or absence
of CD27 expression) were not significantly different in children
with malaria compared to controls.
DISCUSSION
Perturbations of lymphocyte subsets in the context of different
clinical forms of malaria have long been recognized (19, 20),
but lymphocyte subset profiles also vary markedly with age,
particularly in early childhood (17). Using careful malaria sub-
type case definitions and analysis of results with age, we have
confirmed that the immunophenotype profiles of different
forms of severe malaria are linked to the infection itself rather
than patient age. Of the three clinical presentations of malaria
examined, changes in lymphocyte distributions were most
marked in children with cerebral malaria, where a panlym-
phopenia was observed affecting all three main lymphocyte
subsets and T cell subsets. Normalization of lymphocyte num-
bers in convalescence indicates that the observed panlym-
phopenia is transient and is consistent with this not being a
predisposing cause of cerebral malaria. The closely matching
percent cell count distributions for cerebral malaria and
healthy children indicate that the panlymphopenia is almost all
attributable to changes in the total lymphocyte count.
The observation that panlymphopenia is most marked in
cerebral malaria while absent in severe malaria anemia is some-
what counterintuitive, given the apparent role of T cell-depen-
dent immunopathology in the pathogenesis of cerebral ma-
laria, characterized by high levels of proinflammatory
cytokines (9, 10). This apparent paradox may be partly ex-
plained by the fact that only 5% of recirculating lymphocytes
are present in peripheral blood, with lymphocytes principally
FIG 2 Absolute T lymphocyte subset counts (CD4, CD8, and 	 T cell) in children with cerebral malaria (CM), severe malaria anemia (SMA), or
uncomplicated malaria (UCM) and aparasitemic children. CD4, CD8, and 	 T cell counts in peripheral blood at acute presentation with CM (turquoise),
SMA (dark blue), or UCM (green) compared with healthy children (red). Counts shown for individual children against age with nonparametric regression line
(left column) and box-and-whisker plots (middle column; boxes, interquartile ranges; whiskers, data ranges excluding outliers). Tables (right column) give
Dunn’s pairwise post hoc statistical comparisons of groups where Kruskal-Wallis and nonparametric ANCOVA comparisons of data across groups gave P values
of0.05. All P values were adjusted with Benjamini-Hochberg corrections for multiple comparisons.
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developing immune responses within secondary lymphoid
compartments of the spleen and lymph nodes. Lymphopenia
has previously been described in the context of clinical malaria
(21, 22) and has been attributed to temporary sequestration of
cells in secondary lymphoid tissue (13, 23) or to lymphocyte
apoptosis (24, 25). While absolute lymphocyte counts were
normalized in convalescence from cerebral and uncomplicated
malaria, it is striking that this recovery is characterized by a
reduction in the proportion of B cells, leading to a persistent B
cell lymphopenia following cerebral malaria. Given that anti-
body is key to development of natural immunity to malaria,
this relative lack of B cells could predispose the affected chil-
dren to reinfection with malaria. Perturbations of T cell subsets
in severe malarial anemia and uncomplicated malaria resulted
in increased proportions of children with reversed CD4/CD8
ratios (ratio of 1.0). Such a result has been proposed as a
surrogate for HIV infection in African children (26). There-
fore, the CD4/CD8 ratio should not be used in this way in the
presence of active clinical infections, particularly malaria.
Changes in lymphocyte subsets in uncomplicated malaria
reflect those in cerebral malaria, albeit to a lesser degree and
with a smaller transient panlymphopenia. This is consistent
with uncomplicated malaria representing an intermediate im-
munologic manifestation between the polarized extremes of
severe malarial anemia and cerebral malaria (Fig. 5). Median
lymphocyte subset values in children with severe malarial ane-
mia are very similar to those of control children, but with a
wider distribution of values, particularly for absolute lympho-
cyte subset counts. This could reflect a state of immunological
naivety and/or unresponsiveness, particularly given the pre-
dominance of severe malarial anemia among younger children,
resulting in the development of severe disease in this form of
malaria. Such children may be best protected through immu-
nization when licensed vaccines against malaria become avail-
able. Lymphocyte activation demonstrated by expression of
CD69 is characteristic of all three clinical forms of malaria. This
is most apparent with cerebral malaria, and excessive lympho-
cyte activation could contribute to pathogenesis. What is un-
expected is the high proportion of CD69-expressing NK and 	
T lymphocytes. If the immunopathology of cerebral malaria
results from priming of T lymphocytes by previous exposure to
malaria (9), activation would be anticipated most in the adap-
tive CD4 and CD8 lymphocyte populations. A possible ex-
planation is that malaria immunopathology is driven by innate
lymphocytes and that cerebral malaria results when this arm of
the immune response is triggered through inherent suscepti-
bility to overrespond or through priming. Both NK cells and 	
T cells have been implicated in the production of proinflam-
matory cytokines gamma interferon (IFN-) and tumor necro-
sis factor alpha (TNF-) in malaria (27–29).
The increased activation of lymphocytes in cerebral malaria
provides a potential clue concerning the correct explanation
for malaria panlymphopenia. CD69 interacts with sphingosine
1-phosphate receptor 1 in secondary lymphoid tissue, leading
to the halting of lymphocyte transit, preventing their return to
the circulation (30). If this occurs in malaria, the reduction in
lymphocyte surface CD69 expression in convalescence would
enable the rapid restoration of circulating lymphocyte levels
observed posttherapy (13). This explanation for the panlym-T
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phopenia could be further investigated by the examination of
secondary lymphoid tissues in postmortem studies of children
with different forms of malaria. A need for T cell priming in the
pathogenesis of cerebral malaria is supported by increased
memory to naive CD4 lymphocytes compared with control
children. No such increase is seen among CD8T cell and B cell
subsets. Consistent with the immunologic polarization con-
cept for different clinical forms of malaria, a smaller increase in
memory CD4 T cells is found among children with uncom-
plicated malaria, while the median ratio for severe malarial
anemia is the same as that for controls.
There are limitations to the current study. While lympho-
cyte subsets were enumerated and characterized, the antigen
specificity of T and B cells for malaria and other pathogens was
not investigated. Children who were febrile due to causes other
than malaria were not included, so we are unable to compare
our findings of changes in lymphocyte subsets with those in
other febrile illnesses. Further studies are required to address
these points.
The immunologic polarization of these different forms of
clinical malaria raises a key question concerning cause and
effect. Are some African children predisposed toward develop-
ing cerebral malaria and others to severe malarial anemia,
while the majority suffer from only uncomplicated malaria,
and what is the role of prior immunologic priming? To under-
stand this will require further studies but has potential impli-
cations for clinical management, particularly of children with
the severe forms of malaria. If children who develop severe
malarial anemia represent a state of prior immune naivety,
such children may stand to benefit the most from vaccination
against malaria. Meanwhile, children who develop cerebral
malaria may have a combination of prior immunological prim-
ing to malaria and an underlying disposition to immunopatho-
genesis. Such children may require other clinical interventions,
particularly when their malaria is refractory to standard ther-
apy. Caution is required here since a trial in the Gambia of
monoclonal antibody to TNF- for children with cerebral ma-
laria resulted in no improvement in survival and an increase in
neurological sequelae (31). The challenge of applying these
findings to vaccine development is more difficult. Since vac-
cines are given to healthy children, it is not clear at the time of
vaccination whether a child has an inherent predisposition to-
ward cerebral malaria or severe malaria anemia. Studies follow-
ing children in malarious regions longitudinally will help us to
better understand which children are susceptible to developing
either form of severe malaria and provide further scope for
lymphocyte subset evaluation with time in individual children
both in health and in disease.
FIG 3 Percentages of activated lymphocytes in children with cerebral malaria (CM), severe malaria anemia (SMA), or uncomplicated malaria (UCM) and
aparasitemic children. Percentages of T, NK, and 	 T lymphocytes expressing activation marker CD69 in peripheral blood at acute presentation with CM
(turquoise), SMA (dark blue), or UCM (green) compared with healthy children (red). Counts shown for individual children against age with nonparametric
regression line (left column) and box-and-whisker plots (middle column; boxes, interquartile ranges; whiskers, data ranges excluding outliers). Tables (right
column) give Dunn’s pairwise post hoc statistical comparisons of groups where Kruskal-Wallis and nonparametric ANCOVA comparisons of data across groups
gave P values of0.05. All P values were adjusted with Benjamini-Hochberg corrections for multiple comparisons.
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